Benitec BiopharmaBNTC
13F holders, Q4 2024 (December 31)30holders +5
7new positions
3sold out
$12.64avg. 13F price*
At the end of Q4 2024, 30 institutions reported holding Benitec Biopharma Inc. (BNTC) in their 13F filings, up 5 from Q3 2024. 7 opened new positions and 3 sold out. The largest holders were Montanova Capital, LLC ($113.2M), Franklin Resources Inc. ($37.1M) and Janus Henderson Group PLC ($33.3M).
- Company
- Benitec Biopharma Inc.
- CUSIP
- 08205P209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $2.0M |
| Exits | 3 | $956K |
All 13F filers, Q3 2024 → Q4 2024: 5,752,585 shares bought and 679,711 shares sold, net +5,072,874 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| Montanova Capital, LLC | 4.19% | Add +1.5% | 8,960,009 | $113.2M |
| Franklin Resources Inc. | 0.01% | Add +269.0% | 2,939,287 | $37.1M |
| Janus Henderson Group PLC | 0.02% | Add +198.5% | 2,616,427 | $33.3M |
| Adage Capital Partners Gp, L.L.C. | 0.04% | Add +134.4% | 1,972,524 | $24.9M |
| Nantahala Capital Management, LLC | 0.74% | No change | 838,095 | $10.6M |
| Vanguard Group Inc. | 0.00% | Add +40.8% | 300,021 | $3.8M |
| Schonfeld Strategic Advisors LLC | 0.02% | Reduce -4.5% | 260,417 | $3.3M |
| Infinitum Asset Management, LLC | 1.40% | — | 210,000 | $2.7M |
| Geode Capital Management, LLC | 0.00% | Add +134.7% | 197,096 | $2.5M |
| BlackRock, Inc. | 0.00% | Add +515.3% | 173,753 | $2.2M |
| AWM Investment Company, Inc. | 0.16% | Reduce -83.7% | 102,027 | $1.3M |
| Simplify Asset Management Inc. | 0.07% | Reduce -34.5% | 76,337 | $964K |
| Lion Point Capital, LP | 4.10% | Add +59.0% | 62,000 | $783K |
| MYDA Advisors LLC | 0.18% | New | 50,000 | $632K |
| Morgan Stanley | 0.00% | Add +3099.9% | 42,367 | $535K |
| Northern Trust Corp. | 0.00% | Add +54.2% | 38,200 | $482K |
| 683 Capital Management, LLC | 0.05% | New | 35,817 | $452K |
| Ameriprise Financial Inc. | 0.00% | Add +138.4% | 35,476 | $448K |
| Susquehanna International Group, LLP | 0.00% | New | 24,772 | $313K |
| Qube Research & Technologies Ltd | 0.00% | New | 20,896 | $264K |
| State Street Corp. | 0.00% | New | 16,090 | $203K |
| Citigroup Inc. | 0.00% | New | 12,463 | $157K |
| GAMMA Investing LLC | 0.01% | Reduce -1.5% | 6,444 | $81K |
| UBS Group AG | 0.00% | Add +160.6% | 5,013 | $63K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +377.8% | 1,099 | $14K |
| NewEdge Advisors, LLC | 0.00% | Add +10.0% | 671 | $8K |
| Rhumbline Advisers | 0.00% | No change | 186 | $2K |
| Royal Bank of Canada | 0.00% | New | 173 | $2K |
| Bank of America Corp. | 0.00% | Add +117.7% | 148 | $2K |
| Group One Trading LLC | 0.00% | No change | 89 | $1K |
"% of holder's portfolio" is BNTC's weight in each manager's 13F, not the share of Benitec Biopharma Inc. the manager owns.